2 options
Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease / [prepared by Alan M. Garber ... and others].
- Format:
- Book
- Government document
- Series:
- Background paper (United States. Congress. Office of Technology Assessment)
- Background paper
- Language:
- English
- Subjects (All):
- Gaucher disease--Treatment--United States.
- Gaucher disease.
- Orphan drugs--United States.
- Orphan drugs.
- Gaucher disease--Treatment.
- United States.
- Pharmaceutical policy--United States.
- Pharmaceutical policy.
- Physical Description:
- 1 online resource (vii, 34 pages) : illustrations, digital, PDF file.
- monochrome
- Place of Publication:
- Washington, DC : Office of Technology Assessment : For sale by the U.S. Government Printing Office, Superintendent of Documents, [1992]
- System Details:
- System requirements: PDF reader software.
- text file
- Notes:
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
- Includes bibliographical references (pages 29-34).
- Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Research Digital Collection. Mode of access: World Wide Web via ProQuest website.
- Other Format:
- Microfiche version: Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease CIS 92 J952-64
- Print version: Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.